Effect of sleep loss on C-Reactive protein, an inflammatory marker of cardiovascular risk

Journal of the American College of Cardiology

Volumn 43, Issue 4, 2004, Pages 678-683

  Meier Ewert, Hans K ^a,b   Ridker, Paul M ^c   Rifai, Nader ^d   Regan, Meredith M ^e   Price, Nick J ^f   Dinges, David F ^f   Mullington, Janet M ^e,g  

^a LAHEY HOSPITAL AND MEDICAL CENTER   (United States)

^b TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d BOSTON CHILDREN S HOSPITAL   (United States)

^e HARVARD MEDICAL SCHOOL   (United States)

^f UNIVERSITY OF PENNSYLVANIA   (United States)

^g BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

Analysis of variance; Blood pressure; C reactive protein; General Clinical Research Center; Heart rate; Interleukin; Partial sleep deprivation; Total sleep deprivation

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN;

ADULT; ARTICLE; BLOOD; BLOOD PRESSURE; BLOOD PRESSURE MEASUREMENT; BLOOD SAMPLING; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HEART RATE; HUMAN; HUMAN EXPERIMENT; INFLAMMATION; MALE; MONITORING; NIGHT SLEEP; NORMAL HUMAN; PHYSIOLOGY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; RISK; SLEEP DEPRIVATION; SYSTOLIC BLOOD PRESSURE; TIME; WAKEFULNESS;

EID: 1242295176     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2003.07.050     Document Type: Article

References (44)

1. Appels A., de Yos Y., van Diest R., et al. Are sleep complaints predictive of future myocardial infarction? Activitas Nervosa Superior. 29:1987;147-151.
2. Eaker E.D., Pinsky J., Castelli W.P. Myocardial infarction and coronary death among women psychosocial predictors from a 20-year follow-up of women in the Framingham study . Am J Epidemiol. 135:1992;854-864.
3. Schwartz S.W., Cornoni-Huntley J., Cole S.R., et al. Are sleep complaints an independent risk factor for myocardial infarction. Ann Epidemiol. 8:1998;384-392.
4. Newman A.B., Spiekerman C.F., Enright P., et al. Daytime sleepiness predicts mortality and cardiovascular disease in older adults. J Am Geriatr Soc. 48:2000;115-123.
5. Kripke D.F., Garfinkel L., Wingard D.L., et al. Mortality associated with sleep duration and insomnia. Arch Gen Psychiatry. 59:2002;131-136.
6. Ayas N.T., White D.P., Manson J.E., et al. A prospective study of sleep duration and coronary heart disease in women. Arch Intern Med. 163:2003;205-209.
7. Liu Y., Tanaka H. Overtime work, insufficient sleep, and risk of non-fatal acute myocardial infarction in Japanese men. Occup Environ Med. 59:2002;447-451.
8. Dinges D.F., Douglas S.D., Zaugg L., et al. Leukocytosis and natural killer cell function parallel neurobehavioral fatigue induced by 64 hours of sleep deprivation. J Clin Invest. 93:1994;1930-1939.
9. Born J., Lange T., Hansen K., et al. Effects of sleep and circadian rhythm on human circulating immune cells. J Immunol. 158:1997;4454-4464.
10. Shearer W.T., Reuben J.M., Mullington J., et al. Soluble tumor necrosis factor-alpha receptor I and IL-6 concentrations in humans subjected to the sleep deprivation model of space flight. J Allergy Clin Immunol. 107:2001;165-170.
11. Vigushin D.M., Pepys M.B., Hawkins P.N. Metabolic and scintigraphic studies of radioiodinated human C-reactive protein in health and disease. J Clin Invest. 91:1993;1351-1357.
12. Morley J.J., Kushner I. Serum C-reactive protein concentrations in disease. Ann NY Acad Sci. 389:1982;406-418.
13. Castell J.V., Gomez-Lechion M.J., David M., et al. Acute phase response of human hepatocytes regulation of acute-phase protein synthesis by interleukin-6 . Hepatology. 12:1990;1179-1186.
14. Herity N.A. Interleukin-6 a message from the heart . (editorial) Heart. 84:2000;9-10.
15. Meier-Ewert H.K., Ridker P.M., Rifai N., et al. Absence of diurnal variation of C-reactive protein concentrations in healthy human subjects. Clin Chem. 47:2001;426-430.
16. Ridker P.M., Rifai N., Pfeffer M.A., et al. Long-term effects of pravastatin on plasma concentration of C-reactive protein. Circulation. 100:1999;230-235.
17. Rifai N., Tracy R.P., Ridker P.M. Clinical efficacy of an automated high-sensitivity C-reactive protein assay. Clin Chem. 45:1999;2136-2141.
18. Danesh J., Whincup P., Walker M., et al. Low grade inflammation and coronary heart disease prospective study and updated meta-analyses . BMJ. 321:2000;199-204.
19. Ridker P.M. High-sensitivity C-reactive protein potential adjunct for global risk assessment in the primary prevention of cardiovascular disease . Circulation. 103:2001;1813-1818.
20. Lagrand W.K., Visser C.A., Hermens W.T., et al. C-reactive protein as a cardiovascular risk factor more than an epiphenomenon? Circulation. 100:1999;96-102.
21. Pasceri V., Willerson J.T., Yeh E.T.H. Direct proinflammatory effect of C-reactive protein on human endothelial cells. Circulation. 102:2000;2165-2168.
22. Zwaka T.P., Hombach V., Torzewski J. C-reactive protein-mediated low density lipoprotein uptake by macrophages implications for atherosclerosis . Circulation. 103:2001;1194-1197.
23. Shamsuzzaman A.M., Winnicki M., Lanfranchi P., et al. Elevated C-reactive protein in patients with obstructive sleep apnea. Circulation. 105:2002;2462-2464.
24. Vgontzas A.N., Papanicolaou D.A., Bixler E.O., et al. Circadian interleukin-6 secretion and quantity and depth of sleep. J Clin Endocrinol Metab. 84:1999;2603-2607.
25. Maislin G., Rogers N.L., Price N.J., et al. Response surface modeling of the effects of chronic sleep restriction with and without diurnal naps. Sleep. 24S:2001;A242.
26. Spath-Schwalbe E., Hansen K., Schmidt F., et al. Acute effects of recombinant human IL-6 on endocrine and central nervous sleep functions in healthy men. J Clin Endocrinol Metab. 83:1998;1573-1579.
27. Vgontzas A.N., Papanicolaou D.A., Bixler E.O., et al. Elevation of plasma cytokines in disorders of excessive daytime sleepiness role of sleep disturbance and obesity . J Clin Endocrinol Metab. 82:1997;1313-1316.
28. Vgontzas A.N., Papanicolaou D.A., Bixler E.O., et al. Sleep apnea and daytime sleepiness and fatigue relation to visceral obesity, insulin resistance, and hypercytokinemia . J Clin Endocrinol Metab. 85:2000;1151-1158.
29. Chae C.U., Lee R.T., Rifai N., Ridker P.M. Blood pressure and inflammation in apparently healthy men. Hypertension. 38:2001;399-403.
30. Kato M., Phillips B.G., Sigurdsson G., Narkiewicz K., Pesek C.A., Somers V.K. Effects of sleep deprivation on neural circulatory control. Hypertension. 35:2000;1173-1175.
31. Meunter N.K., Watenpaugh D.E., Wasmund W.L., Maxwell S.A., Smith M.L. Effects of sleep restriction on orthostatic cardiovascular control in humans. J Appl Physiol. 88:2000;966-972.
32. Lussardi P., Zoppi A., Pretti P., Pesce R.M., Piazza E., Fogari R. Effects of insufficient sleep on blood pressure in hypertensive patients a 24-h study . Am J Hypertens. 12:1999;63-68.
33. Gonzales-Ortiz M., Martinez-Abundis E., Balcazar-Munoz B.R., et al. Effect of sleep deprivation on insulin sensitivity and cortisol concentration in healthy subjects. Diabetes Nutr Metab. 13:2000;80-83.
34. Spiegel K., Leproult R., van Cauter E. Impact of sleep debt on metabolic and endocrine function. Lancet. 354:1999;1435-1439.
35. Ayas N.T., White D.P., Al-Delaimy W.K., et al. A prospective study of self-reported sleep duration and incident diabetes in women. Diabetes Care. 26:2003;380-384.
36. Festa A., D'Agostino R., Howard G., et al. Chronic subclinical inflammation as part of the insulin resistance syndrome the Insulin Resistance Atherosclerosis Study (IRAS) . Circulation. 102:2000;42-47.
37. Pradhan A.D., Manson J.E., Rifai N. C-reactive protein, interleukin-6, and risk of developing type 2 diabetes mellitus. JAMA. 286:2001;327-334.
38. Albert M.A., Danielson E., Rifai N., et al. Effect of statin therapy on C-reactive protein levels. The PRavastatin INflammation/CRP Evaluation (PRINCE) a randomized trial and cohort study . JAMA. 286:2001;64-70.
39. Freeman D.J., Norrie J., Sattar N., et al. Pravastatin and the development of diabetes mellitus evidence for a protective treatment effect in the West of Scotland Coronary Prevention Study . Circulation. 103:2001;357-362.
40. Nieto F.J., Young T.B., Lind B.K., et al. Association of sleep-disordered breathing, sleep apnea, and hypertension in a large community-based study Sleep Heart Health . JAMA. 283:2000;1829-1836.
41. Peppard P.E., Young T., Palta M., et al. Prospective study of the association between sleep disordered breathing and hypertension. N Engl J Med. 342:2000;1378-1384.
42. Weitzman E.D., Zimmerman J.C., Czeisler C.A., et al. Cortisol secretion is inhibited during sleep in normal man. J Clin Endocrinol Metab. 56:1983;352-358.
43. Mullington J., Hermann D., Holsboer F., et al. Age-dependent suppression of nocturnal growth hormone concentrations during sleep deprivation. Neuroendocrinology. 64:1996;233-241.
44. Mohamed-Ali V., Goodrick S., Rawesh A., et al. Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-alpha, in vivo. J Clin Endocrinol Metab. 82:1997;4196-4200.